Science1 publisherNot yet confirmed elsewhere2 min readPublished
Corrected collagen meta-analyses show no link between dose and skin hydration or elasticity
Grimes and Mahto fixed errors in two collagen meta-analyses from 2021 and 2023 and found no significant link between dose and skin hydration or elasticity. Without a dose response, the skin gains reported in short, largely industry-funded trials are harder to attribute to collagen itself.
The Scientist · Science desk
Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction
What happened
- The critique appears in the Journal of Cosmetic Dermatology, written by Trinity College Dublin biostatistician David Robert Grimes and UK dermatologist Anjali Mahto.
- Among the errors they found, which included confused statistical measures, one of the two reviews reported a nonsignificant finding as significant.
- An overwhelming share of the pooled studies were industry-funded or had authors with commercial ties to collagen manufacturers.
- Most randomized collagen trials run so far lasted only 8 to 12 weeks.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- constraint A trial that could settle the question needs a placebo matched for collagen's taste and mouthfeel, because participants who can tell which arm they are in weaken the control.
- decision Dermatologists fielding patient questions about collagen now have a published case, from Grimes and Mahto, for keeping it out of routine care until the evidence improves.
- cost Buyers of a bestselling supplement are paying for skin benefits that, on the corrected numbers, show no significant link to how much collagen they take.
A dose gradient is one of the few checks a pooled analysis can run on itself. If trial participants who took more collagen gained more hydration than those who took less, chance and bias would struggle to explain the pattern. There was a range to test. In one of the meta-analyses Grimes and Mahto examined, daily doses ran from 0.3 to 10 grams [7], a spread of about 33-fold [19].
Dose was not the only thing that varied. Trials enrolled young or old participants and ran for different lengths of time [6], and some paired collagen with other bioactive ingredients [8]. "Previous meta-analyses and investigations have made little effort to account for this methodological limitation, rendering it even more difficult to attribute observed effects specifically to hydrolyzed collagen," Grimes and Mahto wrote [9].
The reanalysis does not test whether collagen does anything for skin. A recent review linked the supplements to some improvement in elasticity and hydration, with larger gains reported after longer use [20]. Losing the dose relationship [4] leaves those results standing, but it makes them harder to pin on collagen itself. Small, mixed trials [6] can hide a real gradient as well as inflate an overall effect. I think the evidence for collagen as a skin treatment is weaker than its bestseller status implies [18]. The reanalysis removes one supporting signal and leaves the overall effect unproven either way.
How collagen would reach the skin is also uncertain. Hydrolyzed collagen is broken into peptides that dissolve more easily and may be easier to digest [10]. Some animal studies suggest part of that material reaches the skin. Research in humans is lacking [11].
ScienceAlert's report of the paper does not identify which of the two reviews contained the misreported result or include the corrected effect sizes [3].
Grimes and Mahto stated their conclusion plainly. "Despite the growing popularity of hydrolyzed collagen supplements as an intervention for skin aging, the current clinical evidence base remains methodologically fragile, inconsistent, and prone to bias," they wrote [14]. They left room for future evidence. "Collagen may yet have a role in dermatology," they wrote, "but at present, its promotion as a validated anti-aging intervention is premature and not scientifically defensible" [15].
What to watch
- A response or formal correction from the authors of the 2021 and 2023 meta-analyses to the statistical errors Grimes and Mahto identified.
- Randomized trials longer than 12 weeks, free of manufacturer funding, using placebos matched for collagen's taste and mouthfeel.
- Human studies measuring whether ingested collagen peptides actually reach the skin.